Published in Telemedicine Business Week, June 15th, 2005
The findings are the result of a national U.K. study (MARIBS) funded by the Medical Research Council, led by Martin Leach of The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, and published online May 16, 2005, in The Lancet.
Past research indicates around 2% of breast cancer is due to the breast cancer gene mutations BRCA1 and BRCA2. Women with one of these gene mutations come from families where there is a strong family risk of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.